Abstract
Background T1 mapping cardiovascular magnetic resonance (CMR) imaging has been used to characterize pericardial effusions. The aim of this study was to measure pericardial fluid native T1 values in healthy volunteers to establish normal values.
Methods Prospectively recruited volunteers (n=30) underwent CMR at 1.5T and native T1 maps were acquired using a MOLLI 5s(3s)3s acquisition scheme. A volume of pericardial fluid was imaged in a short-axis slice and in a slice perpendicular to the short-axis orientation. A reliable measurement had a region of interest size >10 mm2, coefficient of variation <10 %, and a relative difference <5 % between the two slice orientations.
Results In 26/30 (87%) of volunteers, there was a sufficient amount of pericardial fluid to enable reliable measurement. Native T1 of pericardial fluid was 3262±163 (95% normal limits 2943–3581ms), and did not differ in the perpendicular slice orientation (3267±173 ms, p=0.75), due to sex (female 3311±177 vs. male 3220±142 ms, p=0.17), or age (R2=0.07, p=0.2)
Conclusions This study shows that T1 values can be reliably measured in the pericardial fluid of healthy volunteers. It is the first to report normal reference ranges for T1 values at 1.5T in the pericardial fluid of healthy volunteers.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
The Swedish Heart Lung Foundation
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The study was approved by the Swedish Ethical Review Authority and conducted according to the principles of the Declaration of Helsinki.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Footnotes
Results regarding contrast excretion into pericardial fluid has been removed and will be published in a separate article at a later date.
Data Availability
All data produced in the present study are available upon reasonable request to the authors
